Morocco Continues Chloroquine Use Despite WHO Suspension and Safety Concerns

Chloroquine treatment is the subject of much criticism following the damning report of a study on the risks associated with its use. While the WHO has decided to temporarily suspend clinical trials with hydroxychloroquine, Morocco maintains its use.
For a member of the government, "opinions differ" on the subject. According to him, the essential thing is that chloroquine intervenes in viral inactivation. "The virus infects the host by entering the cell in several stages. One of the stages is inhibited by chloroquine," he insisted.
At the beginning of this month, the minister announced on television that the use of chloroquine "gives good results". According to Aït Tayeb, the observation on the ground is the same regarding the effectiveness of the treatment.
"It’s not just us who say so, but the same observation is made internationally. We have noticed since the adoption of this treatment on March 23 that patients recover faster than those admitted to the hospital before them," he points out. He also adds that this protocol can reduce the viral load in 6 or 7 days, in addition to allowing the patient not to go to intensive care.
Related Articles
-
US Reaffirms Support for Morocco’s Autonomy Plan in Western Sahara Dispute
21 April 2025
-
Moroccan National Arrested at Ceuta Border with 45 Kilos of Cannabis in SUV
20 April 2025
-
Moroccan King’s Eco-Friendly Cosmetics Brand Expands to European Markets
20 April 2025
-
Moroccan Lawyer Wins Court Case Against Gendarmes Over Speeding Ticket Dispute
20 April 2025
-
Trump Considers Shifting US Troops from Spain to Morocco in Strategic Move
20 April 2025